These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10450995)

  • 1. Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme.
    Wu T; Samaranayake LP; Leung WK; Sullivan PA
    J Med Microbiol; 1999 Aug; 48(8):721-730. PubMed ID: 10450995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of secreted aspartyl proteinases of Candida species in human whole saliva.
    Wu T; Samaranayake LP
    J Med Microbiol; 1999 Aug; 48(8):711-720. PubMed ID: 10450994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.
    Wu T; Wright K; Hurst SF; Morrison CJ
    Antimicrob Agents Chemother; 2000 May; 44(5):1200-8. PubMed ID: 10770752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.
    Naglik JR; Challacombe SJ; Hube B
    Microbiol Mol Biol Rev; 2003 Sep; 67(3):400-28, table of contents. PubMed ID: 12966142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and saliva antibodies do not inhibit Candida albicans Sap2 proteinase activity using a BSA hydrolysis assay.
    Naglik JR; Scott J; Rahman D; Mistry M; Challacombe SJ
    Med Mycol; 2005 Feb; 43(1):73-7. PubMed ID: 15712610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases.
    Blanco MT; Hurtado C; Pérez-Giraldo C; Morán FJ; González-Velasco C; Gómez-García AC
    Med Mycol; 2003 Apr; 41(2):167-70. PubMed ID: 12964850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans.
    Schaller M; Krnjaic N; Niewerth M; Hamm G; Hube B; Korting HC
    J Med Microbiol; 2003 Mar; 52(Pt 3):247-249. PubMed ID: 12621090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro.
    Gruber A; Speth C; Lukasser-Vogl E; Zangerle R; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunopharmacology; 1999 Apr; 41(3):227-34. PubMed ID: 10428651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors.
    White TC; Agabian N
    J Bacteriol; 1995 Sep; 177(18):5215-21. PubMed ID: 7665510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
    Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of the secretory aspartyl proteinase in Candida albicans cell wall in vitro and in experimentally infected rat vagina.
    Stringaro A; Crateri P; Pellegrini G; Arancia G; Cassone A; De Bernardis F
    Mycopathologia; 1997; 137(2):95-105. PubMed ID: 9335153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients.
    Kumar CP; Kumar SS; Menon T
    Mycopathologia; 2006 Apr; 161(4):213-8. PubMed ID: 16552483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application in Candida infection.
    Yordanov M; Dimitrova P; Patkar S; Saso L; Ivanovska N
    Can J Microbiol; 2008 Jun; 54(6):435-40. PubMed ID: 18535628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal antibodies for detection of a secreted aspartyl proteinase from Candida spp. in biologic specimens.
    Rodrigues JA; Höfling JF; Azevedo RA; Gabriel DL; Tamashiro WM
    Hybridoma (Larchmt); 2007 Aug; 26(4):201-10. PubMed ID: 17725381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of lysozyme and lanoconazole on the morphology of Candida albicans.
    Nishiyama Y; Nakaoka C; Hiratani T; Abe S; Uchida K; Yamaguchi H
    J Electron Microsc (Tokyo); 2001; 50(1):41-9. PubMed ID: 11291959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.
    Pericolini E; Gabrielli E; Amacker M; Kasper L; Roselletti E; Luciano E; Sabbatini S; Kaeser M; Moser C; Hube B; Vecchiarelli A; Cassone A
    mBio; 2015 Jun; 6(3):e00724. PubMed ID: 26037125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans secreted aspartyl proteinases.
    Hube B
    Curr Top Med Mycol; 1996 Dec; 7(1):55-69. PubMed ID: 9504059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
    Lian CH; Liu WD
    Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secreted aspartic proteinases as a new target in the therapy of candidiasis.
    Bein M; Schaller M; Korting HC
    Curr Drug Targets; 2002 Oct; 3(5):351-7. PubMed ID: 12182226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.
    Colina AR; Aumont F; Deslauriers N; Belhumeur P; de Repentigny L
    Infect Immun; 1996 Nov; 64(11):4514-9. PubMed ID: 8890200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.